Belite Bio
Biotechnology Research · 11 Employees
- Overview
- Employees
Access 13 Verified Employees Profiles for Belite BioUnlock Free Contacts Now
About
Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.
Website
Year Founded
2018
Social Media
LinkedinFacebook
Industry
Biotechnology Research
HQ Location
5820 Oberlin Drive, Suite 101
San Diego, California 92121, US
Keywords
RBP4Drug DevelopmentDry Age-Related Macular DegeneratioStargardt DiseaseDiabetesNASHNAFLD
Location
- 5820 Oberlin Drive, Suite 101 San Diego, California 92121, US
Email Formats
Sign up for free credits and discover verified email addresses of Belite Bio
FormatExamples
first + last
andywarhol@belitebio.com
first_initial + last
awarhol@belitebio.com
first + last_initial
andyw@belitebio.com
first
andy@belitebio.com
last
warhol@belitebio.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Belite Bio and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.